Gland Pharma Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is IRON DEXTRAN COMPLEX, with a corresponding US DMF Number 27823.
Remarkably, this DMF maintains an Active status since its submission on June 10, 2015, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of June 15, 2016, and payment made on July 28, 2015, indicating their dedication to facilitating drug approvals, Categorized as Type II